Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C7LY
|
||||
Former ID |
DNC008790
|
||||
Drug Name |
WAY-207024
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540952] | ||
Structure |
Download2D MOL |
||||
Formula |
C30H32N6
|
||||
InChI |
InChI=1S/C30H32N6/c1-30(2,3)23-10-8-22(9-11-23)29-33-25-5-4-6-27(28(25)34-29)36-17-15-35(16-18-36)20-21-7-12-24-26(19-21)32-14-13-31-24/h4-14,19H,15-18,20H2,1-3H3,(H,33,34)
|
||||
InChIKey |
AVEVJMZJJJDOCI-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Histamine H2 receptor | Target Info | Inhibitor | [530005] | |
NK-2 receptor | Target Info | Inhibitor | [530005] | ||
Gonadotropin-releasing hormone receptor | Target Info | Inhibitor | [530791] | ||
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References | |||||
Ref 530005 | J Med Chem. 2009 Apr 9;52(7):2148-52.Discovery of 6-({4-[2-(4-tert-butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline (WAY-207024): an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R). | ||||
Ref 530791 | Bioorg Med Chem Lett. 2010 Apr 15;20(8):2512-5. Epub 2010 Mar 3.Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptor. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.